Rare diseases
Investigational molecules
Locations
296 conditions with trials, the busiest first
591 trials across Europe, recruiting first
BelgiumA study to test how well empagliflozin works and how safe it is for children and teenagers with chronic kidney disease
BelgiumA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
Belgium
PolandStudy of N-803 combined with BCG treatment for patients with early-stage bladder cancer that has not invaded the muscle wall
GermanyStudy of vicadrostat and empagliflozin given together or separately in people with chronic kidney disease to test safety and effectiveness
BelgiumStudy of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease
BelgiumStudy of Felzartamab for Patients with Late Antibody-Mediated Rejection After Kidney Transplant
AustriaStudy on How Kidney Function Affects the Drug GS-5245 in Patients With Normal and Impaired Kidney Function
GermanyStudy on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment
AustriaStudy on Hyperpolarized [1-13C]Pyruvate and Meglumine Gadoterate for Patients with Diabetic Kidney Disease
DenmarkStudy on the Effects of Camostat Mesilate for Kidney Protection in Patients with Chronic Kidney Disease and Proteinuria
DenmarkThe therapies tested most often in Renal and urinary disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
